Else Nutrition Commends Trump Administration's Expanded Commitment to Bolstering Infant Formulas Regulation in FY2027

President's Budget requested significant FDA funding increases, signaling growing support for Else's next-generation plant-based infant formula Builds Upon FY26 Congressional Appropriations Directive Report Language to Implement and Modernize Guidance for Plant-Based, Non-Soy, Non-Dairy Infant Formulas VANCOUVER, BC, April 15, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) ("Else" or the "Company"), a pioneer in whole-food plant-based, non-soy, non-dairy nutrition for early childhood and adult nutrition, today commended recent actions by the Trump Administration and the U.S. Food and Drug Administration (FDA) that signal increasing support for innovation and modernization within the infant formula market.